Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹4,851 Cr
verified against source
Revenue YoY
14%
reported change
EBITDA
₹614 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Apollo Hospitals reported a strong Q3 FY24 with consolidated revenue of INR 4,851 crore (+14% YoY) and EBITDA of INR 614 crore (+21% YoY). PAT surged 56% YoY to INR 245 crore, driven by robust healthcare services growth (12% YoY) and a significant milestone: Apollo HealthCo achieved break-even a quarter early. Hospital occupancy stood at 66%, with ARPOB up 10% to INR 56,368. Management guided for 200 bps margin improvement in healthcare services over the next few quarters, supported by volume growth and cost rationalization. The 24/7 digital platform is expected to break even in 6-8 quarters, with new revenue streams like insurance distribution and digital therapeutics. A 2,000-bed expansion plan over four years is underway. Key risk: new bed additions may temporarily pressure margins if ramp-up is slower than expected.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects 15% revenue growth for the full year, with Q3 impacted by seasonality but confident of achieving at least 14%.
- Internal target to increase EBITDA margins by 200 basis points through volume growth, clinical program expansion, and cost rationalization.
- Digital platform expected to achieve profitability within six to eight quarters, driven by new verticals like insurance distribution and digital therapeutics.
- Expansion plan includes new hospitals in Pune, Hyderabad, Kolkata, and brownfield in Bangalore, with first beds operational in FY25.
Risks flagged
- New hospitals in Pune, Hyderabad, and Kolkata may initially drag margins due to ramp-up costs, though management expects minimal impact.
- Q3 saw lower elective surgeries due to holidays and Chennai cyclone, affecting revenue mix and margins. Similar events could recur.
- Despite adding 2 million new users, daily active users declined sequentially, raising concerns about user engagement and monetization.
- Allegations of involvement in a kidney racket could impact reputation, though management states no negative findings have been made.
Key quotes
- We have delivered ahead of time on a bit of break-even for Apollo HealthCo. I'm sure we will continue to deliver on our strategic intent.
- Internally, we would like to believe that there is an opportunity to increase the margins by at least 200 basis points over the next few quarters.
- Our entire growth is being led by volume. We are bullish that we'll be able to sustain at 20% kind of growth levels.
Research modules